Verve to Present Interim Data from the heart-1 Phase 1b Clinical Trial of VERVE-101 in HeFH Patients at the American Heart Association’s Scientific Sessions 2023
Company to hold investor event in conjunction with data presentation on November 12, 2023BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) --...
Read moreDetails